Drug Approval | September 23, 2024
Bavarian Nordic receives EMA approval of mpox vaccine for adolescents
MVA-BN approved for use against mpox and smallpox in adolescents 12-17 years of age after expedited review with EMA
MVA-BN approved for use against mpox and smallpox in adolescents 12-17 years of age after expedited review with EMA
Pharmaceuticals and Consumer Health report higher sales (Fx & portfolio adj.) and lower earnings
PICCOLO trial met its primary endpoint of objective response rate (ORR)
Data support the potential of Dupixent as the first new treatment approach in more than a decade and first-ever targeted therapy for COPD
Vision loss due to Glaucoma can be prevented if it is detected and treated early
The U.S. FDA recently approved Xolair as the first and only medicine for children and adults with one or more food allergies
If approved, Xolair would be the first medicine to reduce allergic reactions to multiple foods following an accidental exposure
We are redesigning Bayer to focus only on what’s essential for our mission, ‘Health for all, hunger for none’”
Alignment of carbon-fiber can be controlled during the 3D printing process
Approximately 60 to 78% of individuals diagnosed with Asthma also have concurrent Allergic Rhinitis
Subscribe To Our Newsletter & Stay Updated
